← Back to the biomarker database

Clostridioides difficile: the pathway in the body

This page shows the biochemical pathway behind the laboratory value Clostridioides difficile (GDH, toxin A and B): which stations follow one another, which enzymes carry out each step and which cofactors they use. Every statement has a source. The page describes general textbook knowledge and says nothing about any individual person.

In brief

Clostridioides difficile is a spore-forming gut bacterium that lives without oxygen. In the large intestine it can form two proteins, toxin A and toxin B, which enter the cells of the lining and break down the cell scaffold there.

11 stations · 14 sources
ORYRoute through the gutResponse of the liningGallensalzeSporenbildungToxin A und Toxin BToxin reaches the cell layerSporesDormant form, no metabolismGerminationSignal: primary bile saltsGut florareworks bile saltsColonisationMucus layer of the colonToxin A and toxin BFormed when food runs shortEntry into the cellToxin reaches the cytosolSpores in the stoolGDH and toxins in the testColonic cellsMucus and a tight cell layerNeutrophilsmove into the gut wallWater and saltsRelease into the gut lumenAntibodies to the toxinsIgG in blood, IgA in the gut

Swipe the graphic sideways

The pathway step by step

Each station states what the compound does there. Three signs: ↑ supplies — builds up or makes available · ↓ depletes — inhibits, consumes or withholds · ↕ both, depending on amount. Behind it stands what the statement rests on: established physiology, observed in studies, or contested. The signs do not grade; they name the direction.

  1. Spores → Germination · Gallensalze In the small intestine the spore meets bile salts from the liver. Certain ones, above all cholate, bind a sensor on the spore and let the coats open. A dividing cell emerges from it. Source 3, 4↕ both, depending on amount Primary bile salts are the signal for germination; forms reworked by gut bacteria, such as deoxycholate, hold it back. The same molecular scaffold drives the process or slows it, depending on how it has been reworked. observed in studies Source 3, 4, 5
    ⚖ When the balance tips

    too much — Where primary bile salts prevail, more spores germinate, and more dividing cells reach the large intestine.

    too little — Where the forms reworked by gut bacteria prevail, more spores stay closed and pass through the gut unchanged.

    observed in studies · Source 4, 5

  2. Germination → Colonisation The dividing cell lives without oxygen and settles in the mucus layer of the large intestine. It breaks down sugars and amino acids from the gut contents and divides. Source 6, 14↓ depletes As sugars and amino acids are broken down the number of cells grows; at the same time they occupy space in the mucus layer that other bacteria would otherwise hold. observed in studies Source 6, 14
    ⚖ When the balance tips

    too much — Where much free sugar is available, the cells divide quickly, and their number in the mucus layer grows.

    too little — Where little is available, the number stays small; the organism may then be present without forming toxins in detectable amounts.

    observed in studies · Source 6, 7, 14

  3. Colonisation → Spores in the stool Sporenbildung Some of the cells form spores again and leave the body with the stool. In the laboratory, GDH is measured from the same sample as a sign of the organism, and toxin A and toxin B alongside it. Source 3, 7↑ supplies The spores carry the organism onwards: they persist on surfaces and hands and germinate again in another gut. What arrives in the stool also settles what the test finds. established physiology Source 3, 7
    ⚖ When the balance tips

    too much — Where many spores and much toxin are shed, both tests come out clearly.

    too little — Where few are shed, toxin may stay below the threshold of detection while GDH still shows that the organism is present.

    established physiology · Source 7

  4. Colonisation → Toxin A and toxin B As food runs out, the organism switches to forming two proteins: toxin A and toxin B. The enzyme GDH, by contrast, it forms at all times. In stool the two are measured separately. Source 1, 7, 14↑ supplies Toxin formation hangs on metabolism: when sugars and amino acids run short, the organism switches it on. Toxin B acts on cells more strongly than toxin A; some strains form toxin B only. observed in studies Source 1, 14
    ⚖ When the balance tips

    too much — Where many cells form toxins, more of it reaches the lining, and the stool test finds both proteins.

    too little — Where they form hardly any toxin, often only GDH is detectable in stool: the organism is present without toxins being found.

    observed in studies · Source 7, 14

  5. Toxin A and toxin B → Entry into the cell Toxin A und Toxin B Both toxins bind proteins of the colonic cell and are absorbed in vesicles. Inside, part of the toxin passes into the cell water and there reaches the switches that order the cell scaffold. Source 1, 2↓ depletes In the cell water the toxins attach a sugar to Rho switches and thereby turn them off. The scaffold of actin collapses, the cell loses its shape, and the junctions to neighbouring cells loosen. observed in studies Source 1, 2
    ⚖ When the balance tips

    too much — Where much toxin reaches the cell interior, more junctions come apart, and water and salts pass into the gut lumen.

    too little — Where little reaches the interior, the scaffold stays ordered, and the cell layer holds tight.

    observed in studies · Source 1, 2, 13

    Field of research — The action of the toxins on the cell scaffold is studied in reviews on inflammation of the colonic lining. Source 2

  6. Colonic cells → Neutrophils Neutrophil granulocytes are the first immune cells to move into the gut wall. They engulf bacteria and release substances that remodel the surroundings. Proteins such as calprotectin arise in the process and can be measured in stool. Source 8↕ both, depending on amount Neutrophils hold the organism in check and add to the inflammation themselves: the substances they release dissolve further tissue, and part of it appears as calprotectin in the stool. observed in studies Source 8
    ⚖ When the balance tips

    too much — Where many neutrophils move in, inflammation of the wall grows, and more calprotectin appears in the stool.

    too little — Where few move in, the organism spreads further in the mucus layer.

    observed in studies · Source 8

  7. Neutrophils → Water and salts The inflamed lining reverses its transport: instead of absorbing sodium and water, it releases chloride and water into the gut lumen. The stool becomes thin, and the body loses salts. Source 13↓ depletes Signalling molecules of inflammation slow sodium uptake and drive chloride release. Water follows the salt osmotically into the gut lumen. observed in studies Source 13
    ⚖ When the balance tips

    too much — Where much chloride is released, much water follows, and the loss of salts grows.

    too little — Where transport runs as usual, sodium and water are absorbed, and the stool stays formed.

    observed in studies · Source 13

  8. Colonic cells → Antibodies to the toxins B cells form antibodies that bind the toxins before these reach the cells. In gut mucus it is mainly IgA, in blood IgG. How much is formed differs from person to person. Source 8↑ supplies Antibodies bind the toxins and deny them access to the cell. In observational studies, people with much antitoxin IgG more often carry the organism without symptoms. observed in studies Source 8
    ⚖ When the balance tips

    too much — Where much antitoxin antibody is present, more toxin is bound before it binds to cells.

    too little — Where little is present, more toxin reaches the cells of the lining.

    observed in studies · Source 8

    Field of research — The part played by antibodies against the toxins is studied in reviews on immune defence in the gut. Source 8

Further stations

Cofactors in this pathway

Sources

  1. Aktories K et al. Clostridium difficile Toxin Biology. Annu Rev Microbiol 2017 · PubMed 28657883
  2. Alam MZ et al. Clostridioides difficile Toxins: Host Cell Interactions and Their Role in Disease Pathogenesis. Toxins (Basel) 2024 · PubMed 38922136
  3. Shen A. Clostridioides difficile Spores: Bile Acid Sensors and Trojan Horses of Transmission. Clin Colon Rectal Surg 2020 · PubMed 32104157
  4. Lawler AJ et al. A Revised Understanding of Clostridioides difficile Spore Germination. Trends Microbiol 2020 · PubMed 32781028
  5. McMillan AS et al. Bile acids impact the microbiota, host, and C. difficile dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics. Gut Microbes 2024 · PubMed 39224076
  6. Woelfel S et al. Intestinal colonization resistance in the context of environmental, host, and microbial determinants. Cell Host Microbe 2024 · PubMed 38870899
  7. Barbut F et al. Laboratory diagnosis of Clostridioides difficile infection: past, present and future. Anaerobe 2025 · PubMed 40412504
  8. Wang L et al. Understanding host immune responses in Clostridioides difficile infection: Implications for pathogenesis and immunotherapy. Imeta 2024 · PubMed 38898983
  9. DiGuilio KM et al. Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy. Int J Mol Sci 2022 · PubMed 35328419
  10. Fakhoury HMA et al. Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation. J Steroid Biochem Mol Biol 2020 · PubMed 32194242
  11. Blachier F et al. Metabolism and functions of L-glutamate in the epithelial cells of the small and large intestines. Am J Clin Nutr 2009 · PubMed 19571215
  12. Bos A et al. The role of retinoic acid in the production of immunoglobulin A. Mucosal Immunol 2022 · PubMed 35418672
  13. Das S et al. The Role of Ion Transporters in the Pathophysiology of Infectious Diarrhea. Cell Mol Gastroenterol Hepatol 2018 · PubMed 29928670
  14. Dureja C et al. An integrated view of metabolic and physiological regulation of toxin production in Clostridioides difficile. J Bacteriol 2026 · PubMed 42734620

Related pathways

As of 2026-10-05. Draft, written by Claude to schema v2; sources checked in PubMed; expert approval pending
Legal notice Privacy policy All biomarkers